# LabBase

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/labbase

- Industry: Outsourcing
- Headquarters: Tokyo, Japan
- Website: https://labbase.co.jp/
- Total disclosed funding: $14M
- Latest round: Series B (Sep 15, 2022)
- Investors on record: 7

## About

Based in Japan, LabBase, Inc. specializes in providing advanced laboratory management solutions and analytical tools for the healthcare sector, improving operational efficiency and data management for research and clinical applications.LabBase, Inc. was founded in 2016 and is headquartered in Tokyo, Japan. The company focuses on developing software and tools that streamline laboratory operations. Michiaki Kamo serves as both the founder and CEO. LabBase has successfully closed four funding rounds, with the most recent being a SERIES B round in September 2022, raising JPY 600 million from JIC Venture Growth Investments and other individual investors. The total amount raised to date stands at JPY 600 million, with a current company valuation of JPY 7,333.139 million.LabBase offers a range of specialized products and services designed primarily for the laboratory and healthcare sectors. Their core offerings include laboratory management software that enhances workflow efficiency, along with various analytical tools for data collection and analysis. These products address critical operational challenges in laboratory efficiency, data management, and regulatory compliance. The company serves a diverse clientele, including hospitals, research institutions, and pharmaceutical companies, aiming to improve access to data and operational support for laboratory technicians and researchers. LabBase markets its solutions extensively across North America, Europe, and specific parts of Asia.LabBase generates its revenue through a structured model that includes both direct sales and subscription-based services, focusing on B2B transactions with institutional clients. The company provides tiered subscription plans for its laboratory management software, which encompass features like cloud storage, data analytics, and compliance tracking. Clients enter agreements that facilitate monthly or annual access to the software, ensuring they receive continuous support and updates. Additionally, LabBase offers consulting services that enhance product implementation, further contributing to its revenue stream by partnering with hospitals and research facilities.In September 2022, LabBase, Inc. raised JPY 600 million in SERIES B financing to bolster its growth initiatives. The company intends to utilize these funds to recruit additional software and research engineers. LabBase is actively developing new products aimed at enhancing laboratory operations and plans to expand into new markets, specifically targeting regions where advanced laboratory capabilities are crucial, with initiatives expected to roll out by the end of 2024.

## Funding rounds

- Series B, Sep 15, 2022, $4.2M — JIC Venture Growth Investments
- Series A, Sep 17, 2019, $9.3M — CyberAgent Capital, BEENEXT, Beyond Next Ventures, Spiral Capital, PKSHA Technology
- Seed, May 2, 2017, $0.5M — CyberAgent Capital, DNX Ventures, BEENEXT, Beyond Next Ventures

## Investors

- CyberAgent Capital (https://capitalatlas.ai/funds/cyberagent-capital) — Seed, Series A
- DNX Ventures (https://capitalatlas.ai/funds/dnx-ventures) — Seed
- BEENEXT (https://capitalatlas.ai/funds/beenext) — Seed, Series A
- Beyond Next Ventures (https://capitalatlas.ai/funds/beyond-next-ventures) — Seed, Series A
- Spiral Capital (https://capitalatlas.ai/funds/spiral-capital) — Series A
- PKSHA Technology — Series A
- JIC Venture Growth Investments (https://capitalatlas.ai/funds/jic-venture-growth-investments) — Series B